Advertisement

Reactions Weekly

, Volume 1713, Issue 1, pp 81–81 | Cite as

Carboplatin/gefitinib/paclitaxel

Loss of appetite and peripheral nerve damage: case report
Case report
  • 14 Downloads

Reference

  1. Hirabae A, et al. Concurrent administration of an epidermal growth factor receptor tyrosine kinase inhibitor and cytotoxic anticancer drug to treat epidermal growth factor receptor gene mutation-positive and mutation-negative lung cancers. [Japanese]. Haigan / Japanese Journal of Lung Cancer 58: 127-131, No. 2, 2018. Available from: URL: http://doi.org/10.2482/haigan.58.127 [Japanese; summarised from a translation] - JapanCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations